APA (7th ed.) Citation

C, R., V, C., S, S., L, B., C, R., M, M., . . . MP, C. (2022). Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling. Molecular cancer, 21(1), 215. https://doi.org/10.1186/s12943-022-01687-6

Chicago Style (17th ed.) Citation

C, Rizzello, et al. "Intracellular Osteopontin Protects from Autoimmunity-driven Lymphoma Development Inhibiting TLR9-MYD88-STAT3 Signaling." Molecular Cancer 21, no. 1 (2022): 215. https://doi.org/10.1186/s12943-022-01687-6.

MLA (9th ed.) Citation

C, Rizzello, et al. "Intracellular Osteopontin Protects from Autoimmunity-driven Lymphoma Development Inhibiting TLR9-MYD88-STAT3 Signaling." Molecular Cancer, vol. 21, no. 1, 2022, p. 215, https://doi.org/10.1186/s12943-022-01687-6.